Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

Abstract

We have identified discriminatory gene expression signatures working both on untreated and systematically treated primary breast cancer patients with the potential to spare them from adjuvant therapy.